LICHA KAI
No ORCID on file
· 24 papers in corpus
· active 2006-2010
Frequent coauthors
- SCHIRNER MICHAEL 24
- Hauff Peter 16
- PERLITZ CHRISTIN 16
- BAHNER MALTE 8
- PESSEL MARTIN 8
2010
Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…
2010
Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…
2010
Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…
2010
Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…
2010
Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…
2010
Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…
2010
Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…
2010
Disclosed is the use of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a diagnostic composition for the detection of a proliferative disease (such as a tumor, a precancerosis, a dys…
2007
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2007
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2007
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2007
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2007
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2007
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2007
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2007
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2006
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2006
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2006
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2006
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2006
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2006
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2006
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…
2006
This invention relates to the use of conjugates of cyanine dyes with an angiogenesis specific binding component preferably with an EB-D fibronectin specific binding component for the diagnosis of micrometastasis and small proliferative lesi…